Cell type-specific roles of PAR1 in Coxsackievirus B3 infection
Tomohiro Kawano, Vanthana Bharathi, Yohei Hisada, Michael F. Bode et autres
us (code pays fourni par la source)
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
Tomohiro Kawano, Vanthana Bharathi, Yohei Hisada, Michael F. Bode et autres
us (code pays fourni par la source)
Pia Weinländer, Sara Hadzibegovic, Jan Porthun, Lucie Kretzler et autres
BACKGROUND: Patients with advanced cancer frequently suffer from frailty associated with vulnerability and adverse outcomes. Our aim was to assess the prevalence of frailty and elucidate the utility of two commonly used frailty questionnaires in an advanced cancer population. METHODS: The Fried …
de, us, no, gr, gb (code pays fourni par la source)
Raj S. Kasthuri, Yohei Hisada, Håkan Wallén, Angela M. Taylor et autres
us (code pays fourni par la source)
Coleen A. McNamara, Fariborz Mobarrez, Yohei Hisada, Håkan Wallén et autres
us (code pays fourni par la source)
Colinda van Deutekom, Karina V Bunting, Tom J. R. De Potter, Isabelle C. Van Gelder et autres
Colinda van Deutekom, Karina V Bunting, Tom J R De Potter, Isabelle C Van Gelder, Dipak Kotecha, on behalf of the, STEEER-AF education leads , Thompson Rob
nl, gb, be, br (code pays fourni par la source)
Elham Ghanbari, Ulrike Meyer, Andrea Doerner, Margaret T. Kasner et autres
Abstract Background and Aims Obesity is considered a major risk factor for the development of heart failure (HF) due to lipid accumulation, oxidative stress and inflammation which results in cardiac remodeling. Protease activated receptor 2 (PAR2) has been linked to various cardiovascular …
de (code pays fourni par la source)
Maciej M. Sterlinski, Karina V Bunting, Giuseppe Boriani, Serge Bovéda et autres
AIMS: The aim is to describe the rationale, design, delivery, and baseline characteristics of the Stroke prevention and rhythm control Treatment: Evaluation of an Educational programme of the European society of cardiology in a cluster-Randomized trial in patients with Atrial Fibrillation (STEEER-AF) …
pl, gb, it, fr, es, de, nl (code pays fourni par la source)
Julian Friebel, Max Wegner, Leon Blöbaum, Philipp-Alexander Schencke et autres
Patients with first-diagnosed atrial fibrillation (FDAF) exhibit major adverse cardiovascular events (MACEs) during follow-up. Preclinical models have demonstrated that thrombo-inflammation mediates adverse cardiac remodeling and atherothrombotic events. We have hypothesized that thrombin activity (FIIa) links coagulation with inflammation and cardiac fibrosis/dysfunction. Surrogate …
de (code pays fourni par la source)
Ann‐Kathrin Fröhlich, Jan Porthun, Khawaja Muhammad Talha, Alessia Lena et autres
Abstract Background Growth hormone (GH) resistance is characterized by high GH levels but low levels of insulin-like growth factor-I (IGF-I) and growth hormone binding protein (GHBP) and, for patients with chronic disease, is associated with the development of cachexia. Objectives We investigated …
de, no, us, gb, au (code pays fourni par la source)
Denitsa Meteva, Ramona Vinci, Claudio Seppelt, Youssef Salah Abdelwahed et autres
BACKGROUND AND AIMS: In one-third of patients with acute coronary syndrome (ACS), thrombosis occurs despite an intact fibrous cap (IFC) (IFC-ACS, 'plaque erosion'). Recent studies emphasize neutrophils as the immediate inflammatory response in this pathology, but their exact molecular activation patterns are …
de, it, ie (code pays fourni par la source)
Marianna Puccini, Kai Jakobs, Leander Reinshagen, Julian Friebel et autres
Galectin-3 is a beta-galactoside-binding lectin involved in inflammation and lung fibrosis and postulated to enhance thrombosis. In COVID-19, it is considered to be a prognostic marker of severity. The aim of this study was to evaluate whether galectin-3 is associated with thrombogenicity …
de (code pays fourni par la source)
Erik Asmus, Weronika Karle, Markus C. Brack, Corey Wittig et autres
Cystic fibrosis transmembrane conductance regulator (CFTR) modulators reduce agonist-induced platelet activation and function. CFTR modulators, such as ivacaftor, present a promising therapeutic strategy in thrombocytopathies, including severe COVID-19. https://bit.ly/3HJykdt
de, nl, ca (code pays fourni par la source)
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.
L'essentiel de l'actu tech du Burkina & d'Afrique, chaque semaine dans votre boîte mail.
Gratuit · sans spam · désinscription en un clic